Bristol Myers Squibb is raising its full-year outlook after blood thinner sales surged past expectations

Quartz

Strong sales of blood thinner Eliquis and newer drugs Camzyos and Reblozyl pushed second-quarter revenue to $12.97 billion, above analyst estimates ...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

관련 뉴스

관련 뉴스 제보는 로그인 후 가능합니다.

'economy' 카테고리 뉴스

Quartz의 다른 기사

8 heat waves in history that changed how cities are built

Quartz

The 5 best cookware sets under $300 according to Consumer Reports

Quartz

The most fuel-efficient hybrids under $35k, according to Consumer Reports

Quartz

Bristol Myers Squibb is raising its full-year outlook after blood thinner sales surged past expectations

이 뉴스, 어떠셨어요?

관련 뉴스

'economy' 카테고리 뉴스

Group 1 Q2 2026 slides: Atlanta expansion amid earnings miss

Xcel Energy Q2 2026 slides: $70B capital plan drives 24% EPS growth

Life Time Q2 2026 slides show membership quality driving growth

Quartz의 다른 기사

8 heat waves in history that changed how cities are built

The 5 best cookware sets under $300 according to Consumer Reports

The most fuel-efficient hybrids under $35k, according to Consumer Reports